By Robert Rowley MD – Emerging laboratory technology and the forefront of biological study have begun to amass large reservoirs of data, newly referred to as “-omics” – genomics, transcriptomics, proteomics, metabolomics. The list is increasing.
Read More
By Robert Rowley MD – We are now at a time when modern technology has made gene sequencing of an individual’s DNA a reality. DNA sequencing of certain sections of a genome is used routinely in forensics now.
By Robert Rowley MD – The outcome of the recent election caught many people, and many forecasters, by surprise. How could their predictions have missed the mark so significantly?
By Robert Rowley MD – A recently published study in JAMA Internal Medicine showed that clinical depression is poorly diagnosed and often goes untreated. 46,000 Americans screened for depression found that 8.4% of those interviewed had depression.
By Robert Rowley MD – A recent article by The Commonwealth Fund raises the question of being able to use smartphone apps to get real-time, accurate and personalized guidance for health concerns. While one can envision the convenience, affordability and peace of mind that would result from their use, such services face a number of hurdles before they become reality.
On our next Healthcare De Jure, host Matt Fisher and his guests discuss the use of Artificial Intelligence in patient engagement and care coordination. Join the conversation at #HCdeJure.
By Robert Rowley MD – One of the most frustrating elements of the current healthcare environment is the administrative burden of prior authorizations for medications and procedures. It is a frustration for providers, for patients, and for payers. Is there any way to solve this dilemma?
By Alex Meshkin – We have seen incredible progress in machine learning and artificial intelligence (AI) over the past few years, especially through the application of deep learning algorithms. AI systems will get even better as more data is collected, so faster data gathering and better data integration should lead to smarter and more useful AI systems.
By Robert Rowley MD – The way we pay for healthcare is changing. The transition from fee-for-service (“fee for volume”) to value-based care is beginning to take shape, and will do so increasingly in the next few years. Federal pressures as well as private industry pressures are driving this change, as reviewed nicely in a white paper by Houlihan Lokey, “Value-Based Care.”